| Chairman |
|
Zhao Lu |
| Business Nature |
| 醫療保健 (Health Care) |
| Board Members |
Chairman: Zhao Lu
Executive Director: Ma Dong, Zhang Hongwei, Lu Yiming, Huang Yufei, Ni Xiaomei
Independent Non-executive Director: Jiang Xiao, Li Zhiguo, Fung Che Wai Anthony.
|
| Principle Business |
|
The Group is principally engaged in the provision of pharmaceutical and medical device R&D and commercialization digital solutions. |
| Major Shareholders |
| Zhao Lu | 178,203,028 | NON-H SHS | 31.61% | 49.07% | 2024/12/31 | | TENCENT HOLDINGS LTD. | 51,911,405 | NON-H SHS | 9.21% | 14.29% | 2024/12/31 | | Zuo Lingye & ASSO | 30,061,593 | H Sh | 5.33% | 14.99% | 2024/12/31 | | Zuo Lingye & ASSO | 23,908,953 | NON-H SHS | 4.24% | 6.58% | 2024/12/31 | | Zhang Pengpeng | 15,930,449 | NON-H SHS | 2.83% | 4.39% | 2024/12/31 | | Zhang Pengpeng | 15,930,449 | H Sh | 2.83% | 7.94% | 2024/12/31 | | Shanghai Xingpan Investment Management Consulting Co., Ltd. | 15,538,280 | H Sh | 2.76% | 7.75% | 2024/12/31 | | TENCENT HOLDINGS LTD. | 12,977,851 | H Sh | 2.30% | 6.47% | 2024/12/31 | | Shanghai Xingpan Investment Management Consulting Co., Ltd. | 12,358,096 | NON-H SHS | 2.19% | 3.40% | 2024/10/08 | | Zhang Xu & ASSO | 12,285,138 | H Sh | 2.19% | 6.23% | 2024/12/31 | | Yan Yan | 10,889,262 | H Sh | 1.93% | 5.43% | 2024/12/31 | | Tang Meng | 10,694,479 | H Sh | 1.91% | 5.42% | 2024/12/31 | | Zheshang Venture Capital Co., Ltd. | 10,094,225 | H Sh | 1.79% | 5.03% | 2024/12/31 | | Zheshang Venture Capital Co., Ltd. | 10,094,225 | NON-H SHS | 1.79% | 2.78% | 2024/10/08 | | Zhang Xu & ASSO | 9,770,766 | NON-H SHS | 1.76% | 2.69% | 2024/12/31 | | Tang Meng | 8,505,665 | NON-H SHS | 1.51% | 2.34% | 2024/12/31 | | Zhao Lu | 1,216,500 | H Sh | 0.22% | 0.61% | 2024/12/31 |
|
|
|
|
|